Search form

Advanced Search
 
Sunday March 26, 2017

Rutgers Official Named Executive Officer of Big Ten Cancer Research Consortium

News Release
Friday May 30, 2014

Rutgers Official Named Executive Officer of Big Ten Cancer Research Consortium

Your Source for University News
Susan Goodin will work to develop national cancer clinical trials stemming from collaborative science
Media Contact:
Michele Fisher
732-235-9872

Susan Goodin, executive director of statewide affairs at Rutgers Cancer Institute of New Jersey, has been appointed to serve as executive officer of the Big Ten Cancer Research Consortium. Goodin is also a professor of medicine at Rutgers Robert Wood Johnson Medical School.

The consortium, which fosters scientific collaboration between cancer centers at universities that are part of the Big Ten Conference, aims to develop unique nationwide clinical trial opportunities for patients.

Susan Goodin
Photo: Steve Hockstein
Susan Goodin
In this role, Goodin will work closely with the consortium’s administration and member institutions to carry out this mission that has an initial focus of developing treatments for genitourinary, gastrointestinal, thoracic and breast cancers.  

A researcher for more than 20 years, the Cranford resident has helped lead clinical research activity at the Cancer Institute of New Jersey, having served as an associate director of clinical trials and therapeutics. She also has been a principal investigator on a number of translational trials. Goodin also has served as director of the Cancer Institute’s Division of Pharmaceutical Sciences. 

“I am honored to have been selected to serve in this capacity for the Big Ten Cancer Research Consortium,” notes Goodin.  “In an era when targeted cancer therapies are no longer a prediction, but a reality, these elite centers will incorporate their groundbreaking science into novel clinical trials. And by working collaboratively in a consortium environment, we will have the opportunity to elucidate these discoveries rapidly.”

Goodin is a founding member of the Hematology/Oncology Pharmacists Association, serves on the editorial board of Clinical Therapeutics and is a journal reviewer for the New England Journal of Medicine, Clinical Cancer Research and Clinical Therapeutics among others. She also has authored numerous scientific publications and has presented nationally on the topics of cancer treatment, chemoprevention and supportive care. 

Goodin attended the University of Kentucky, where she earned a Doctor of Pharmacy degree after completing a Bachelor of Science degree in pharmacy. She joined Rutgers Cancer Institute of New Jersey in 1993.

Media Contact:
Michele Fisher
732-235-9872
Your Source for University News